// App-Quantinova.ai

: Aspartyl (Asparaginyl) ß hydroxylase (AABH) as a serum bio-marker for prostate cancer to identify prostate cancer, regardless of PSA level.

Researchers

Presenter

  • Mahmood Moshiri

Principal Investigators

  • Kiarash Moshiri

  • Arsha Moshiri

  • Hassan Monhemi

  • Mohammad Hadi Sekhavati

Medical Centers

  • Next Pharma Inc., Richmond Hill, ON, Canada

  • Ferdowsi University, Mashhad, Iran (Islamic Republic of)

Locations

  • Canada

  • Iran

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Prostate specific antigen

  • Aspartyl (Asparaginyl) β-Hydroxylase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved